19.01.2013 Views

Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...

Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...

Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

tered in families. Sporadic cases in which the patient<br />

has <strong>no</strong> affected family members are often seen.<br />

These cases may indeed represent the first ‘FHM’<br />

patient (de <strong>no</strong>vo mutation) in a family. Like FHM,<br />

SHM has an overlapping clinical phe<strong>no</strong>type with<br />

the common forms of migraine; indeed, the diag<strong>no</strong>stic<br />

criteria for SHM are identical to FHM except<br />

for the presence of affected first- or second-degree<br />

relatives (see Table 1). In addition, SHM and <strong>no</strong>rmal<br />

migraine also show a remarkable genetic epidemiological<br />

relationship. SHM patients have a markedly<br />

increased risk of typical migraine with aura,<br />

and first-degree relatives have an increased risk of<br />

both MA and MO. Although an initial study reported<br />

CACNA1A mutations in only 2 of 27 SHM patients,<br />

when this study was expanded, causal mutations<br />

were found in the FHM genes in a higher proportion<br />

of SHM patients, confirming a genetic relationship<br />

between FHM and SHM.<br />

E. FHM4 and beyond<br />

Given the relatively rapid path to the discovery of<br />

three genes linked to FHM, and continually improving<br />

sequencing and screening methods, new FHM<br />

genes will undoubtedly be discovered. This is supported<br />

by reports of FHM families without identified<br />

mutations in any of the three FHM genes. Given the<br />

common pathway in which all three FHM proteins<br />

play a role (see Section VII), it is likely that new candidate<br />

genes will encode proteins that play key roles<br />

in neuronal excitability and/or ion homeostasis.<br />

VI. FUNCTIONAL CONSEQUENCES OF FHM<br />

MUTATIONS<br />

A. CaV2.1 (P/Q-type) calcium channel<br />

(FHM1)<br />

Upon the initial discovery of four missense mutations<br />

in CACNA1A linked to FHM, the path to understanding<br />

how the mutations give rise to the disease<br />

seemed relatively straightforward. However, this<br />

proved to be initially elusive, as functional analyses<br />

of these four mutations yielded conflicting results.<br />

In some cases, mutations gave rise to an apparent<br />

loss of function, while in other cases, a gain-of-function<br />

phe<strong>no</strong>type was observed. This was in stark con-<br />

Natuurkundige <strong>voor</strong>drachten I Nieuwe reeks 89<br />

Migraine: de ontrafeling van een complexe ziekte<br />

trast to CACNA1A mutations linked to EA2, in which<br />

all mutations studied confer a clear loss-of-function<br />

phe<strong>no</strong>type to the channel. To date, 19 FHM1 mutations<br />

have been identified in CACNA1A (Fig. 1), and<br />

most have been studied in heterologous expression<br />

systems. As with the original four mutations, <strong>no</strong><br />

clear pattern of either loss or gain of function initially<br />

emerged. Because of these conflicting results,<br />

researchers turned to expressing recombinant<br />

channels in primary cultured neurons from Cacna1a<br />

k<strong>no</strong>ckout mice lacking endoge<strong>no</strong>us P/Q-type channels.<br />

Four such studies have been published. In three<br />

studies the mutations caused dramatically reduced<br />

whole-cell currents when compared with wild-type<br />

channels. In the fourth, the mutation gave rise to an<br />

increased current density at negative voltages. The<br />

functional consequences of the original four mutations<br />

on synaptic transmission in cultured neurons<br />

were also examined, and, consistent with decreased<br />

whole-cell current density, every mutation caused<br />

impaired synaptic transmission. Despite the evidence<br />

for FHM1 mutations causing a loss-of-function<br />

phe<strong>no</strong>type, increasing evidence was emerging<br />

in support of gain-of-function effects. This evidence<br />

primarily arose from a series of elegant studies<br />

measuring the single-channel properties of channels<br />

bearing FHM mutations. A careful examination<br />

of channel open probability and unitary current<br />

amplitude over a range of voltages revealed that the<br />

mutant channels exhibit a negative shift in voltage<br />

dependence, meaning that the channels open more<br />

readily with less depolarization. This effect was also<br />

reflected in whole-cell currents measured in S218L<br />

channels expressed in Cacna1a k<strong>no</strong>ckout neurons,<br />

in which significantly larger currents were observed<br />

at negative voltages. In all, ten FHM1 mutations,<br />

including all four original mutations, are reported to<br />

activate at more negative voltages than wild-type<br />

channels.<br />

One important lesson learned from these studies<br />

is that reliable functional data can<strong>no</strong>t always be<br />

obtained solely using exoge<strong>no</strong>usly expressed channels.<br />

Many factors, including the origin species of<br />

the channel, the splice variant chosen, the accessory<br />

subunit(s), and the expression level can all influence<br />

115

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!